Enliven Therapeutics (ELVN) Q4 2020 Earnings

5MarExpected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-4.31
-3.06
-1.81
-0.56

Details

Expected EPS
-0.84
Actual EPS
-0.56
Surprise EPS
0.28
Surprise Percent
+33.33%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.56 per share for Q4 2020.

0 Comments

Share your thoughts